Normal view MARC view ISBD view

Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review. [Review]

MedStar author(s):

Citation: Journal of the American College of Cardiology. 80(16):1560-1578, 2022 Oct 18.PMID: 36229093Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Antineoplastic Agents | *Cardiovascular Diseases | *Drug-Related Side Effects and Adverse Reactions | *Heart Diseases | *Neoplasms | Antineoplastic Agents/ae [Adverse Effects] | Artificial Intelligence | Cardiovascular Diseases/co [Complications] | Cardiovascular Diseases/dg [Diagnostic Imaging] | Heart Diseases/di [Diagnosis] | Humans | Medical Oncology | Neoplasms/co [Complications] | Neoplasms/dg [Diagnostic Imaging] | Neoplasms/dt [Drug Therapy]Year: 2022 ISSN:

0735-1097

Name of journal: Journal of the American College of CardiologyAbstract: The population of patients with cancer is rapidly expanding, and the diagnosis and monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in the field of cardio-oncology and imaging have occurred in recent years. This review presents updated and practical approaches for multimodality cardiovascular imaging in the cardio-oncology patient and provides recommendations for imaging to detect the myriad of adverse cardiovascular effects associated with antineoplastic therapy, such as cardiomyopathy, atherosclerosis, vascular toxicity, myocarditis, valve disease, and cardiac masses. Uniquely, we address the role of cardiovascular imaging in patients with pre-existing cardiomyopathy, pregnant patients, long-term survivors, and populations with limited resources. We also address future avenues of investigation and opportunities for artificial intelligence applications in cardio-oncology imaging. This review provides a uniform practical approach to cardiovascular imaging for patients with cancer. Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.All authors: ACC Cardio-Oncology and the ACC Imaging Councils, Ayoub C, Baldassarre LA, Barac A, DeCara JM, Dent S, Deswal A, Ganatra S, Ghosh AK, Henry M, Khemka A, Leja M, Liu JE, Lopez-Mattei J, Rudski L, Scherrer-Crosbie M, Villarraga HR, Wong TC, Yang EH, Zaha VGFiscal year: FY2023 Digital Object Identifier:

https://dx.doi.org/10.1016/j.jacc.2022.08.743

Date added to catalog: 2022-10-27

Holdings ( 1 )
Title notes ( 2 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	36229093	Available		36229093

The population of patients with cancer is rapidly expanding, and the diagnosis and monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in the field of cardio-oncology and imaging have occurred in recent years. This review presents updated and practical approaches for multimodality cardiovascular imaging in the cardio-oncology patient and provides recommendations for imaging to detect the myriad of adverse cardiovascular effects associated with antineoplastic therapy, such as cardiomyopathy, atherosclerosis, vascular toxicity, myocarditis, valve disease, and cardiac masses. Uniquely, we address the role of cardiovascular imaging in patients with pre-existing cardiomyopathy, pregnant patients, long-term survivors, and populations with limited resources. We also address future avenues of investigation and opportunities for artificial intelligence applications in cardio-oncology imaging. This review provides a uniform practical approach to cardiovascular imaging for patients with cancer. Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

English